Según un estudio, una sola dosis de un nuevo fármaco antiviral reduce a la mitad el riesgo de enfermarse de COVID grave
Related Posts
Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
TUESDAY, May 23, 2023 (HealthDay News) -- Patients with COVID-19-associated...
AI May Help Detect Breast Cancer in Mammography Screening Program
WEDNESDAY, June 1, 2022 (HealthDay News) -- An artificial intelligence (AI)...
Smokers, Obese People Need Major Heart Interventions Earlier in Life
FRIDAY, June 11, 2021 (HealthDay News) -- In a finding that confirms healthy...
Topical Gel for Erectile Dysfunction Gets FDA Approval for OTC Sale
TUESDAY, June 13, 2023 (HealthDay News) -- Men with erectile dysfunction will...